On February 23rd, Vator Securities arranged the Vator Securities Tech Day Summit, a digital investor event where you got the opportunity to meet some of the most interesting and innovative companies in Swedish tech.
The participating companies were Rebelle, Plagazi, JonDeTech, InCoax, Waystream, Precise Biometrics, ZignSec and MOVS
Vator Securities advises Precise Biometrics on 83 MSEK Directed & Rights Issue
Precise Biometrics AB is a global identification software provider, offering products with a range of application for identification in a convenient and secure way. Precise offers products with various applications that enable individuals to identify themselves by using biometrics.
Precise operates through two product areas: Digital Identity, which enable identification for physical access through biometrics (e.g., fingerprints, heart rate, facial and iris recognition) and Algo Software systems which is a leading embedded software for fingerprint recognition meeting various needs in smartphones, smart-lock doorhandles, and various applications in cars.
read more
Vator Securities advises Rebelle on 315 MSEK M&A
Rebelle operates the European online marketplace Rebelle.com for selling and buying luxury second hand fashion items and accessories.
Rebelle is offering products from the world’s most sought-after fashion brands, such as Louis Vuitton, Chanel, Gucci, Hermès and Prada while increasing customers awareness of sustainability and circularity within the fashion industry.
read more
Vator Securities advises Movs Technology Group on 45 MSEK Private Placement
Movs Technology Group is today the market leader in electric mopeds, and the leading dealer of electric bikes in Sweden. The company has developed several market-leading brands in Sweden: Baotian, Vässla, Drax, Niu and Lifebike.
The Mobility-as-a-Service service MOVS is a subscription service for long-term rental of bikes, as well as light electric vehicles such as electric bikes and electric mopeds.
read more
Vator Securities acts as Joint Bookrunner on IRRAS 215 MSEK Rights Issue
IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients.
IRRAS designs, develops, and commercializes neurocritical care products that transform patient outcomes and decrease the overall cost of care by addressing complications associated with current treatment methodologies.
read more
83MSEK | Q3 2022
315 MSEK | Q3 2022
45 MSEK | Q3 2022
215 MSEK | Q3 2022
